{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:10:36Z","timestamp":1785186636222,"version":"3.55.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001061","name":"Rebecca L. Cooper Medical Research Foundation","doi-asserted-by":"publisher","award":["F2021894"],"award-info":[{"award-number":["F2021894"]}],"id":[{"id":"10.13039\/501100001061","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Office of Road Safety","award":["RSIF2-51"],"award-info":[{"award-number":["RSIF2-51"]}]},{"name":"Swinburne University of Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s40261-025-01455-6","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:22:57Z","timestamp":1750494177000},"page":"417-429","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Same-Day Sedative and Night-Time Sleep Effects Following Combined Cannabinoid Formulations: A Randomised-Controlled Trial"],"prefix":"10.1007","volume":"45","clinical-trial-number":[{"clinical-trial-number":"actrn12622001539729","registry":"10.18810\/anzctr"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8789-1701","authenticated-orcid":false,"given":"Andrea J.","family":"Narayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5233-8191","authenticated-orcid":false,"given":"Brooke","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-7344","authenticated-orcid":false,"given":"Blair","family":"Aitken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-3192","authenticated-orcid":false,"given":"Luke A.","family":"Downey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4470-4718","authenticated-orcid":false,"given":"Amie C.","family":"Hayley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"issue":"5","key":"1455_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.37349\/emed.2023.00171","volume":"4","author":"A Stueber","year":"2023","unstructured":"Stueber A, Cuttler C. A large-scale survey of cannabis use for sleep: preferred products and perceived effects in comparison to over-the-counter and prescription sleep aids. Exploration of Medicine. 2023;4(5):709\u201319.","journal-title":"Exploration of Medicine."},{"key":"1455_CR2","doi-asserted-by":"crossref","unstructured":"Arkell T, McCartney D, McGregor I. Medical cannabis and driving. Aust J Gen Pract. 2021;50:357\u201362.","DOI":"10.31128\/AJGP-02-21-5840"},{"key":"1455_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115102","volume":"165","author":"ZXB Low","year":"2023","unstructured":"Low ZXB, Lee XR, Soga T, Goh BH, Alex D, Kumari Y. Cannabinoids: Emerging sleep modulator. Biomed Pharmacother. 2023;165: 115102.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"1455_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/medicina56060309","volume":"56","author":"L Poyatos","year":"2020","unstructured":"Poyatos L, P\u00e9rez-Acevedo AP, Papaseit E, P\u00e9rez-Ma\u00f1\u00e1 C, Martin S, Hladun O, et al. Oral Administration of Cannabis and \u0394-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Medicina. 2020;56(6):309.","journal-title":"Medicina"},{"issue":"2","key":"1455_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/jat\/bkx012","volume":"41","author":"R Vandrey","year":"2017","unstructured":"Vandrey R, Herrmann ES, Mitchell JM, Bigelow GE, Flegel R, LoDico C, et al. Pharmacokinetic profile of oral cannabis in humans: blood and oral fluid disposition and relation to pharmacodynamic outcomes. J Anal Toxicol. 2017;41(2):83\u201399.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"1455_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1590\/1516-4446-2020-1684","volume":"44","author":"JA Crippa","year":"2022","unstructured":"Crippa JA, Pereira Junior LC, Pereira LC, Zimmermann PM, Brum Junior L, Rechia LM, et al. Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters. Braz J Psychiatry. 2022;44(1):15\u201320.","journal-title":"Braz J Psychiatry."},{"key":"1455_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104941","volume":"143","author":"AJ Narayan","year":"2022","unstructured":"Narayan AJ, Downey LA, Manning B, Hayley AC. Cannabinoid treatments for anxiety: a systematic review and consideration of the impact of sleep disturbance. Neurosci Biobehav Rev. 2022;143: 104941.","journal-title":"Neurosci Biobehav Rev"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","volume":"32","author":"L Taylor","year":"2018","unstructured":"Taylor L, Gidal B, Blakey G, Tayo B, Morrison G. A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects. CNS Drugs. 2018;32:1053\u201367.","journal-title":"CNS Drugs"},{"issue":"5","key":"1455_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.5664\/jcsm.10998","volume":"20","author":"AJ Narayan","year":"2024","unstructured":"Narayan AJ, Downey LA, Rose S, Di Natale L, Hayley AC. Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing. J Clin Sleep Med. 2024;20(5):753\u201363.","journal-title":"J Clin Sleep Med"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pbb.2018.07.007","volume":"172","author":"JD Nguyen","year":"2018","unstructured":"Nguyen JD, Grant Y, Kerr TM, Gutierrez A, Cole M, Taffe MA. Tolerance to hypothermic and antinoceptive effects of\u2206 9-tetrahydrocannabinol (THC) vapor inhalation in rats. Pharmacol Biochem Behav. 2018;172:33\u20138.","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"1455_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0209947","volume":"14","author":"JL Wilkerson","year":"2019","unstructured":"Wilkerson JL, Schulze DR, McMahon LR. Tolerance and dependence to \u03949-tetrahydrocannabinol in rhesus monkeys: Activity assessments. PLoS ONE. 2019;14(3): e0209947.","journal-title":"PLoS ONE"},{"issue":"2","key":"1455_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","volume":"10","author":"JE Beal","year":"1995","unstructured":"Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J Pain Symptom Manage. 1995;10(2):89\u201397.","journal-title":"J Pain Symptom Manage"},{"key":"1455_CR13","unstructured":"Therapeutic Goods Administration. Medicinal cannabis products by active ingredients: Therapeutic Goods Administration; 2024 [Available from: https:\/\/www.tga.gov.au\/medicinal-cannabis-products-active-ingredients. Accessed 8 Jul 2024."},{"issue":"3","key":"1455_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/a-2261-2269","volume":"57","author":"N Szejko","year":"2024","unstructured":"Szejko N, Becher E, Heimann F, Grotenhermen F, M\u00fcller-Vahl KR. Medicinal use of different cannabis strains: results from a large prospective survey in Germany. Pharmacopsychiatry. 2024;57(3):133\u201340.","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"1455_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s42238-021-00073-1","volume":"3","author":"A Bhaskar","year":"2021","unstructured":"Bhaskar A, Bell A, Boivin M, Briques W, Brown M, Clarke H, et al. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. 2021;3(1):22.","journal-title":"J Cannabis Res"},{"issue":"3","key":"1455_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/00952990.2013.788183","volume":"39","author":"KA Babson","year":"2013","unstructured":"Babson KA, Boden MT, Bonn-Miller MO. Sleep quality moderates the relation between depression symptoms and problematic cannabis use among medical cannabis users. Am J Drug Alcohol Abuse. 2013;39(3):211\u20136.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"1455_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jat\/bks081","volume":"37","author":"DA Gorelick","year":"2013","unstructured":"Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, et al. Tolerance to effects of high-dose oral \u03949-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. J Anal Toxicol. 2013;37(1):11\u20136.","journal-title":"J Anal Toxicol"},{"issue":"3","key":"1455_CR18","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1476-5381.2010.00790.x","volume":"160","author":"LK Vaughn","year":"2010","unstructured":"Vaughn LK, Denning G, Stuhr KL, De Wit H, Hill MN, Hillard CJ. Endocannabinoid signalling: has it got rhythm? Br J Pharmacol. 2010;160(3):530\u201343.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1455_CR19","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s10787-022-01020-z","volume":"30","author":"JD Henson","year":"2022","unstructured":"Henson JD, Vitetta L, Hall S. Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions. Inflammopharmacology. 2022;30(4):1167\u201378.","journal-title":"Inflammopharmacology"},{"key":"1455_CR20","doi-asserted-by":"crossref","unstructured":"Suraev A, McGregor I, Marshall N, D'Rozario A, Kao C, Gordon C, et al. Acute effects of combined cannabidiol (CBD) and \u22069-tetrahydrocannabinol (THC) in insomnia disorder: A randomised, placebo-controlled trial using high-density EEG. Sleep Advances. 2022(2632-5012 (Electronic)).","DOI":"10.1093\/sleepadvances\/zpac029.005"},{"issue":"3","key":"1455_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/01.jcp.0000125688.05091.8f","volume":"24","author":"AN Nicholson","year":"2004","unstructured":"Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Delta-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24(3):305\u201313.","journal-title":"J Clin Psychopharmacol"},{"key":"1455_CR22","doi-asserted-by":"crossref","unstructured":"Strand NH, Maloney J, Kraus M, Wie C, Turkiewicz M, Gomez DA, et al. Cannabis for the treatment of fibromyalgia: a systematic review. Biomedicines. 2023;11(6):1621.","DOI":"10.3390\/biomedicines11061621"},{"issue":"8","key":"1455_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/cbdv.200790150","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB, Guy GW, Robson PJ. Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex\u00ae, a cannabis-based medicine. Chem Biodivers. 2007;4(8):1729\u201343.","journal-title":"Chem Biodivers"},{"key":"1455_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107937","volume":"211","author":"TR Spindle","year":"2020","unstructured":"Spindle TR, Cone EJ, Goffi E, Weerts EM, Mitchell JM, Winecker RE, et al. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users. Drug Alcohol Depend. 2020;211: 107937.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1455_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/occmed\/kqv087","volume":"66","author":"J-K Beck","year":"2016","unstructured":"Beck J-K, Inventory D. Beck depression inventory. Occup Med. 2016;66(2):174\u20135.","journal-title":"Occup Med"},{"issue":"4","key":"1455_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.janxdis.2005.05.004","volume":"20","author":"OT Leyfer","year":"2006","unstructured":"Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord. 2006;20(4):444\u201358.","journal-title":"J Anxiety Disord"},{"issue":"1\u20132","key":"1455_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/00207459008994241","volume":"52","author":"T \u00c5kerstedt","year":"1990","unstructured":"\u00c5kerstedt T, Gillberg M. Subjective and objective sleepiness in the active individual. Int J Neurosci. 1990;52(1\u20132):29\u201337.","journal-title":"Int J Neurosci"},{"issue":"6","key":"1455_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/jat\/bkab124","volume":"46","author":"CL Bergeria","year":"2022","unstructured":"Bergeria CL, Spindle TR, Cone EJ, Sholler D, Goffi E, Mitchell JM, et al. Pharmacokinetic profile of \u22069-tetrahydrocannabinol, cannabidiol and metabolites in blood following vaporization and oral ingestion of cannabidiol products. J Anal Toxicol. 2022;46(6):583\u201391.","journal-title":"J Anal Toxicol"},{"issue":"7","key":"1455_CR29","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.clinph.2006.03.011","volume":"117","author":"K Kaida","year":"2006","unstructured":"Kaida K, Takahashi M, \u00c5kerstedt T, Nakata A, Otsuka Y, Haratani T, et al. Validation of the Karolinska sleepiness scale against performance and EEG variables. Clin Neurophysiol. 2006;117(7):1574\u201381.","journal-title":"Clin Neurophysiol"},{"issue":"11","key":"1455_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142533","volume":"10","author":"VT van Hees","year":"2015","unstructured":"van Hees VT, Sabia S, Anderson KN, Denton SJ, Oliver J, Catt M, et al. A novel, open access method to assess sleep duration using a wrist-worn accelerometer. PLoS ONE. 2015;10(11): e0142533.","journal-title":"PLoS ONE"},{"key":"1455_CR31","unstructured":"National Sleep Foundation. NSF Sleep Dairy Arlington, Virginia: National Sleep Foundation; 2021 [Available from: https:\/\/www.thensf.org\/nsf-sleep-diary\/. Accessed 8 Jul 2024."},{"issue":"1","key":"1455_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41606-024-00109-4","volume":"8","author":"CL Vestergaard","year":"2024","unstructured":"Vestergaard CL, Simpson MR, Sivertsen B, Kallestad H, Langsrud K, Scott J, et al. Weekday-to-weekend sleep duration patterns among young adults and outcomes related to health and academic performance. Sleep Sci Pract. 2024;8(1):15.","journal-title":"Sleep Sci Pract"},{"issue":"9","key":"1455_CR33","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s00213-024-06595-9","volume":"241","author":"A Suraev","year":"2024","unstructured":"Suraev A, McCartney D, Marshall NS, Irwin C, Vandrey R, Grunstein RR, et al. Evaluating possible \u2018next day\u2019 impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial. Psychopharmacology. 2024;241(9):1815\u201325.","journal-title":"Psychopharmacology"},{"key":"1455_CR34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1515\/tnsci-2020-0002","volume":"11","author":"JM Antony","year":"2020","unstructured":"Antony JM, McDonald AC, Noorbakhsh F, Guthrie N, Evans M. Changing the tone of clinical study design in the cannabis industry. Transl Neurosci. 2020;11:4\u20139.","journal-title":"Transl Neurosci"},{"key":"1455_CR35","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018;9:1365.","journal-title":"Front Pharmacol"},{"key":"1455_CR36","doi-asserted-by":"crossref","unstructured":"Niesink RJM, van Laar MW. Does cannabidiol protect against adverse psychological effects of THC? Front Psychiatry. 2013;4:130.","DOI":"10.3389\/fpsyt.2013.00130"},{"issue":"5","key":"1455_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034421","volume":"10","author":"A Suraev","year":"2020","unstructured":"Suraev A, Grunstein RR, Marshall NS, Rozario AL, Gordon CJ, Bartlett DJ, et al. Cannabidiol (CBD) and \u03949-tetrahydrocannabinol (THC) for chronic insomnia disorder (\u2018CANSLEEP\u2019 trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial. BMJ Open. 2020;10(5): e034421.","journal-title":"BMJ Open"},{"issue":"2","key":"1455_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/0748730404273983","volume":"20","author":"S Benloucif","year":"2005","unstructured":"Benloucif S, Guico M, Reid KJ, Wolfe L, L\u2019Hermite-Bal\u00e9riaux M, Zee P. Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. J Biol Rhythms. 2005;20(2):178\u201388.","journal-title":"J Biol Rhythms"},{"issue":"4","key":"1455_CR39","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/can.2019.0037","volume":"4","author":"S Lunn","year":"2019","unstructured":"Lunn S, Diaz P, O\u2019Hearn S, Cahill SP, Blake A, Narine K, et al. Human pharmacokinetic parameters of orally administered \u03b49-tetrahydrocannabinol capsules are altered by fed versus fasted conditions and sex differences. Cannabis Cannabinoid Res. 2019;4(4):255\u201364.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"1455_CR40","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1038\/s41598-025-87621-4","volume":"15","author":"BADF Saals","year":"2025","unstructured":"Saals BADF, De Bie TH, Osmanoglou E, van de Laar T, Tuin AW, van Orten-Luiten ACB, et al. A high-fat meal significantly impacts the bioavailability and biphasic absorption of cannabidiol (CBD) from a CBD-rich extract in men and women. Sci Rep. 2025;15(1):3678.","journal-title":"Sci Rep"},{"issue":"11","key":"1455_CR41","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.5665\/sleep.3142","volume":"36","author":"M Marino","year":"2013","unstructured":"Marino M, Li Y, Rueschman MN, Winkelman JW, Ellenbogen JM, Solet JM, et al. Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography. Sleep. 2013;36(11):1747\u201355.","journal-title":"Sleep"},{"issue":"5","key":"1455_CR42","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/opo.12131","volume":"34","author":"RA Armstrong","year":"2014","unstructured":"Armstrong RA. When to use the Bonferroni correction. Ophthalmic Physiol Opt. 2014;34(5):502\u20138.","journal-title":"Ophthalmic Physiol Opt"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01455-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01455-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T21:22:51Z","timestamp":1757193771000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01455-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01455-6","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"2 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member Institutions. ACH is supported by a Rebecca L Cooper Al and Val Rosenstrauss Fellowship (GNT:F2021894). This study was funded by a grant to ACH from the Australian Office of Road Safety as part of the Road Safety Innovation Fund initiative (RSIF2-51). The sponsors provided funding for the study only. The study treatments were provided by CANN group Ltd. (Melbourne, Australia).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AN, BM, BA, LAD and ACH have no conflicts of interests to declare that go beyond financial interests that could impart bias on the work submitted for publication such as professional interests, personal relationships or personal beliefs (amongst others).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"Swinburne University of Technology\u2019s Human Research Ethics Committee (approval granted: 22\/12\/2022; Ref: 20236915-16331). This trial was performed in accordance with Good Clinical Practice guidelines and the ethical standards of the Declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained prior screening and the enrolment of each participant with ongoing eligibility and consent re-confirmed prior to treatment administration at each testing session.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Data supporting findings in this study are available within the list of tables presented.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"AN: Data collection, formal analysis, visualisation, writing\u2014original draft, writing\u2014review and editing. BM, BA: Data collection, data management, writing\u2014reviewing and editing. LAD: Conceptualization, methodology\/study design, writing\u2014reviewing and editing, funding acquisition. ACH: Conceptualization, methodology\/study design, writing\u2014reviewing and editing, funding acquisition. All authors have read and approved the final version of this manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}